Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccinationViggo Van Tendeloo, Zwi Berneman, Ann Van de Velde et al.|Proceedings of the National Academy of Sciences|2010Cited by 376
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemiaSébastien Anguille, Zwi Berneman, Ann L. Van de Velde et al.|Blood|2017Cited by 235
Overexpression of the Wilms' tumor gene WT1 in esophageal cancer.Yusuke Oji, Haruo Sugiyama, Masahiko Yano et al.|PubMed|2004Cited by 46
The Wilms' Tumor Gene WT1 − 17AA/− KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer ModelKeiko Yamanouchi, Hirohisa Kurachi, Tsuyoshi Ohta et al.|Translational Oncology|2014Cited by 10
WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid LeukemiaZwi Berneman, Viggo Van Tendeloo, Sébastien Anguille et al.|Blood|2010Cited by 6